Nestlé was granted a patent for a cognitive-decline treatment approach.

{
  "signal_id": "26cbbfa9-1c4e-54dd-8bab-90b5e224ced4",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-30T16:46:18+00:00",
  "company": {
    "name": "Nestle",
    "domain": "nestle.com"
  },
  "data": {
    "cpc": [
      {
        "code": "A61K 31/714"
      },
      {
        "code": "A61K 31/14"
      },
      {
        "code": "A61K 31/198"
      },
      {
        "code": "A61K 31/202"
      },
      {
        "code": "A61K 31/592"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Healthcare Technology",
      "Medical Research"
    ],
    "detail": "In September 2026 Nestlé patented a nutrition-based approach for supporting cognitive health, intended for use in dietary and clinical care settings.",
    "summary": "Nestlé was granted a patent for a cognitive-decline treatment approach.",
    "event_at": "2026-09-29",
    "inventors": [
      {
        "name": "Gene Bowman",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/gene-bowman-64b10b8"
      },
      {
        "name": "Julie Hudry-Labbe",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Jeroen Antonius Johannes Schmitt",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Corina Boschat",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Claus Rieker",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-29",
    "source_url": "https://patents.google.com/patent/US12746255",
    "cpc_primary": {
      "code": "A61K 31/714"
    },
    "patent_title": "Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability",
    "patent_number": "US12746255",
    "uspto_assignee": "Societe des Produits Nestle S.A.",
    "patent_abstract": "A method for treating cognitive decline in a subject, the method comprising administering to the subject an omega-3 fatty acids, wherein the omega-3 fatty acid is administered to the subject simultaneously, sequentially or separately with at least one of (i) vitamin D or a metabolite thereof and/or (ii) an agent capable of reducing plasma homocysteine levels.",
    "precision_class": "structural",
    "invention_explanation": "A treatment that combines omega-3 fatty acids with vitamin D or homocysteine-lowering agents to help address cognitive decline.",
    "technologies_mentioned": [
      "nutritional therapeutics",
      "omega-3 fatty acids",
      "vitamin D",
      "cognitive health"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/26cbbfa9-1c4e-54dd-8bab-90b5e224ced4 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"nestle.com","limit":20}'